Global Pharmaceutical Databases

European Pharmaceutical & Biotech Platform

Ask Us (800) 762-3361
Questions or Comments?
Ask us your questions or give us your feedback. Enter your message below and after pressing the Send button it will be sent directly to the individual responsible.
*Required Fields
First Name:* Last Name:*
Company Name: E-Mail Address: *
Phone Number:
Enter your questions, comments and/or feedback:*

(Maximum of 2000 characters)


Note: For the ability to track the status of your request, please login first.

Pharmaceutical & Biotech Industry - New European Coverage

The past few years have been a time of enormous operational changes for the Pharmaceutical-Biotech Industry. Mergers and acquisitions, patent expirations, consolidation, quality concerns--these issues and other market drivers have had a huge impact on how the industry invests its capital dollars and where they are being spent. How do you keep track of what's happening in this dynamic industry?

To reflect today's Pharmaceutical-Biotech Industry, Industrial Info has launched European coverage. Providing a more complete picture of the current life science market, coverage will include both an operational and pre-commissioned plant platform, as well capital investment and maintenance (MRO) projects for both product development and manufacturing.

Encompassing the entire Life Science Industry, coverage will include traditional pharmaceuticals (branded, generic and over-the-counter, biological (cell-based) drugs, diagnostic substances, active pharmaceutical ingredients (APIs), and nutritional supplements. The burgeoning medical device market and major laboratories will be included as well.

Industrial Info provides the most accurate industrial market intelligence available. We uncover the hard-to-get project details and key decision-makers so that our clients can focus on pursuing opportunities efficiently and effectively, while remaining well informed.

Plants and Units

Project Activities

Project Information

Contact us today for more information on the platform and how to subscribe.